Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-39.08	27.10	44.49
Graham Fair Price	17.99	3317.04	2811.25
PEG	-28.74	0.23	-0.33
Price/Book	1.72	1.16	1.14
Price/Cash Flow	inf	0.00	47.27
Prices/Earnings	-24.27	8.60	11.36
Price/Sales	-15.35	1.96	2.32
Price/FCF	inf	0.00	47.27
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-2.86	0.19	0.19
Operating Margin	23.69	0.10	0.08
ROA	33.61	0.01	< 0.005
ROE	0.03	0.03	34.33
ROIC	0.01	0.02	40.75
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.02	0.10	-84.32
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.04	0.48	994.48
EPS QOQ	-0.35	0.37	6.27
FCF QOQ	0.02	-1.00	5257.54
Revenue QOQ	-0.09	0.19	117.38
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	221.40	175.09	-20.92
Days Sales Outstanding (DSO)	40.87	39.83	-2.55
Inventory Turnover	0.41	0.51	26.45
Debt/Capitalization	0.48	0.46	-3.09
Quick Ratio	0.58	0.71	22.14
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	3734.73	3802.08	1.80
Cash	578.17	702.72	21.54
Capex	0.00	0.00	0.00
Free Cash Flow	90.37	0.00	inf
Revenue	1844.04	2255.88	22.33
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	2.32	2.38	2.69
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	17.74	10.36	-41.61
Naive Interpretation	Member

06 - Financial Health · Bad

Rating